iOS app Android app

Robin L. Smith
Dr. Robin L. Smith's expertise in business development and medicine includes her extensive and diversified experience serving in executive and board level capacities for various medical enterprises and healthcare-based entities. Since 2006, Dr. Smith has served as Chairman and CEO of NeoStem, a rapidly growing company in the stem cell sector. In 2010, NeoStem earned the New Economy "Best Stem Cell Company" award. Dr. Smith has successfully led the business in completing five acquisitions as well as raising over 100 million dollars toward building one of the leading companies in the emerging cell therapy industry. From 2000 to 2003, Dr. Smith served as President & Chief Executive Officer of IP2M, a multi-platform media company specializing in healthcare. During her term, the company was selected as being one of the 10 fastest growing technology companies in Houston, Texas. IP2M was sold to a publicly traded company in February 2003. Previously, from 1998 to 2000, Dr. Smith was Executive Vice President and Chief Medical Officer for Health Help, Inc., a National Radiology Management company that managed 14 percent of all healthcare dollars spent by large insurance companies.

Dr. Smith has acted as a senior advisor to, and investor in, both publicly traded and privately held companies where she has played a significant role in restructuring and or growing such businesses. She currently serves on the Board of Trustees of the NYU Langone Medical Center and is past Chairman of the Board of Directors for the New York University Hospital for Joint Diseases where she headed up new development efforts and board member recruitment. Dr. Smith has also served on the Board of Choose Living as well as other public and private companies. Currently, Dr. Smith is the President and serves on the Board of Directors of The Stem for Life Foundation, a non-profit entity with a goal of educating the public about the growing benefits of stem cell therapies and applications. Dr. Smith received a medical degree from Yale University in 1992 and a master's degree in business administration from the Wharton School at the University of Pennsylvania in 1997.

Blog Entries by Robin L. Smith

President Obama and the Embryonic Backfire

(3) Comments | Posted November 7, 2012 | 10:34 AM

As Barack Obama begins his second administration, now is the time to examine the impact his re-election will have on stem cell research and the broader regenerative medicine industry. Before diving into those implications, however, it's important for us to understand how perceptions of stem cell science have changed in...

Read Post